Molecular studies into the role of CD44 variants in metastasis in gastric cancer

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 1, 1999, Pages 25-28

  Hsieh, H F ^b   Yu, J C ^a   Ho, L I ^c   Chiu, S C ^d   Harn, H J ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d Tri Service General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; HERMES ANTIGEN; HYALURONIC ACID; MEMBRANE PROTEIN; MEMBRANE RECEPTOR;

CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; TUMOR DIFFERENTIATION;

EID: 0001873478     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.1.25     Document Type: Review

References (47)

1. 1 Picker LJ, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules in diverse cell types. J Cell Biol 1989;109:927-37.
2. 2 Aruffo AI, Stamenkovic M, Melnick CB, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
3. 3 Hyanes BF, Telen MJ, Hale LP, et al. CD44 . . . a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989;10:423-8.
4. 4 Jalkanen S, Jalkanen M, Bargatze R, et al. Biochemical properties of glycoproteins involved in lympocyte recognition of high endothelial venules in man. J Immunol 1988;141: 1615-23.
5. 5 Jalkanen S, Reichert RA, Gallatin WM, et al. Homing receptors and the control of lymphocyte migration. Immunol Rev 1986;91:39-60.
6. 6 Carter WG, Wayner EA. Characterization of the class III collagen receptor, a phosphorlated transmemhrane glycoprotein expressed in nucleated human cells. J Biol Chem 1988;263:4193-201.
7. 7 Huet S, Grous H, Caillou B, et al. CD44 contributes to T cell activation. J Immunol 1989;143:798-801.
8. 8 Underhill C. CD44: the hayluronan receptor. J Cell Sci 1992;103:293-8.
9. 9 Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991;3:347-50.
10. 10 Berg EL, Doldstein LA, Jutila MA, et al. Homing receptors and vascular addressins: cell adhesion molecles that direct lymphocyte traffic. Immunol Rev 1989;108:5-18.
11. 11 Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993;184:47-63.
12. 12 Stamenkovic I, Amiot M, Pesando LM, et al. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-62.
13. 13 Goldstein LA, Zhou DFH, Picker LJ, et al. A human lymphocyte homing receptor. The Hermes antigen is related to cartilage proteoglycan core and link proteins. Cell 1989;56:1063-72.
14. 14 Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-4.
15. 15 Bargatze RF, Wu NW, Weissman IL, et al. High endothelial venule binding as a predictor of the dissemination of passaged marine lymphoma. J Exp Med 1987;166:1125-31.
16. 16 Toole BP, Biswas C, Gross J. Hyaluronate and invasiveness of the rahbit V2 carcinoma. Proc Natl Acad Sci USA 1979; 76:6299-303.
17. 17 Knudson W, Biswas C, Toole BP. Stimulation of glycosaminoglycan production in murine tumors. J Cell Biochem 1984;25:183-96.
18. 18 Nemec RE, Tool BP, Knudson W. The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells. Biochem Biophys Res Commun 1987;149:249-57.
19. 19 Kimata K, Honma Y, Okyama M, et al. Increased synthesis of hyaluronic acid by mouse mammary-carcinoma-cell variants with high metastasis potential. Cancer Res 1993;43: 1347-54.
20. 20 Turley EA, Tretiak M. Glycosaminoglycan production by murine melanoma variants in vivo and in vitro. Cancer Res 1985;45:5098-105.
21. 21 Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
22. 22 Hofmann M, Ruddy W, Zoller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51:5292-7.
23. 23 Koopman G, Heider KH, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphoma express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993;177:897-904.
24. 24 Salles G, Zain M, Jiang WM, et al. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Blood 1993;82:3539-47.
25. 25 Combaret V, Gross N, Lasset C, et al. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 1996;14:25-34.
26. 26 Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340:1053-68.
27. 27 Fox SB, Gatter KC, Jackson DG, et al. CD44 and cancer screening. Lancet 1993;342:548-9.
28. 28 Horng RL, Lee WJ, Shun CT, et al. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinoma. Oncology 1995;52:334-9.
29. 29 Kainz C, Kohlberger P, Tempfer C, et al. Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer 1995;31A:1706-9.
30. 30 Heider KH, Hofmann M, Jors E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993;120:227-33.
31. 31 Heider KH, Dammrich J, Skroch-Angel P, et al. Differentiation expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinoma and normal gastric mucosa. Cancer Res 1993;53:4197-203.
32. 32 Washington K, Gottfried MR, Telen MJ. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 1994;25:1043-9.
33. 33 Harn HJ, Ho LI, Chang JY, et al. Differentiation expression of human metastasis adhesion molecule CD44V in Chinese stomach carcinoma. Cancer 1995;75:1065-71.
34. 34 Harn HJ, Ho LI, Shyu RY, et al. Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma. J Clin Gastroenterol 1996;22:107-10.
35. 35 Harn HJ, Lee HS, Ho LI, et al. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int 1994;32:233-8.
36. 36 Harn HJ, Lee HS, Ho LI, et al. Selective expression of CD44 messager RNA splice variants in four grade human brain tumor cell lines. Biochem Mol Biol Int 1994;33:742-8.
37. 37 Gansauge F, Gansauge S, Zobywalski A, et al. Differentiation expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer Res 1995;55:5499-503.
38. 38 Manten-Horst E, Danen EHJ, Smit Lia, et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995;64:182-8.
39. 39 Friedrichs K, Franke F, Lisboa BW, et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 1995;55:5424-33.
40. 40 Fox SB, Fawcett J, Jackson DG, et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994;54:4539-46.
41. 41 Guo YJ, Liu G, Wang X, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994;54: 422-6.
42. 42 Harn HJ, Shen KL, Liu CA, et al. Hyaluronate binding assay study of transfected CD44 V4 V7 isoforms into human gastric carcinoma cell line SC-M1. J Pathol 1998;184:291-6.
43. 43 Bennett KL, Modrell B, Greenfield B, et al. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 1995;131:1623-3.
44. 44 Lesley J, English N, Perschl A, et al. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 1995;182:431-7.
45. 45 Katoh S, Zheng Z, Oritani K, et al. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 1995;182:419-29.
46. 46 Deb TB, Datta K. Molecular cloning of human fibroblast hyaluronic acid binding protein confirms its identity wih P-32, a protein co-purified with splicing factor SF2. J Biol Chem 1996;271:2206-12.
47. 47 Konig H, Moll J, Ponta H, et al. Trans-acting factors regulate the expression of CD44 splice variants. EMBO J 1996;15:4030-9.